Microwave Breast Imaging Using Rotational Bistatic Impulse Radar for the Detection of Breast Cancer: Protocol for a Prospective Diagnostic Study.

breast cancer diagnostic accuracy microwave imaging screening ultra-wideband radar

Journal

JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504

Informations de publication

Date de publication:
19 Oct 2020
Historique:
received: 18 12 2019
accepted: 13 08 2020
revised: 24 07 2020
entrez: 19 10 2020
pubmed: 20 10 2020
medline: 20 10 2020
Statut: epublish

Résumé

Mammography is the standard examination for breast cancer screening; however, it is associated with pain and exposure to ionizing radiation. Microwave breast imaging is a less invasive method for breast cancer surveillance. A bistatic impulse radar-based breast cancer detector has recently been developed. This study aims to present a protocol for evaluating the diagnostic accuracy of the novel microwave breast imaging device. This is a prospective diagnostic study. A total of 120 participants were recruited before treatment administration and divided into 2 cohorts: 100 patients diagnosed with breast cancer and 20 participants with benign breast tumors. The detector will be directly placed on each breast, while the participant is in supine position, without a coupling medium. Confocal images will be created based on the analyzed data, and the presence of breast tumors will be assessed. The primary endpoint will be the diagnostic accuracy, sensitivity, and specificity of the detector for breast cancer and benign tumors. The secondary endpoint will be the safety and detectability of each molecular subtype of breast cancer. For an exploratory endpoint, the influence of breast density and tumor size on tumor detection will be investigated. Recruitment began in November 2018 and was completed by March 2020. We anticipate the preliminary results to be available by summer 2021. This study will provide insights on the diagnostic accuracy of microwave breast imaging using a rotational bistatic impulse radar. The collected data will improve the diagnostic algorithm of microwave imaging and lead to enhanced device performance. Japan Registry of Clinical Trials jRCTs062180005; https://jrct.niph.go.jp/en-latest-detail/jRCTs062180005. DERR1-10.2196/17524.

Sections du résumé

BACKGROUND BACKGROUND
Mammography is the standard examination for breast cancer screening; however, it is associated with pain and exposure to ionizing radiation. Microwave breast imaging is a less invasive method for breast cancer surveillance. A bistatic impulse radar-based breast cancer detector has recently been developed.
OBJECTIVE OBJECTIVE
This study aims to present a protocol for evaluating the diagnostic accuracy of the novel microwave breast imaging device.
METHODS METHODS
This is a prospective diagnostic study. A total of 120 participants were recruited before treatment administration and divided into 2 cohorts: 100 patients diagnosed with breast cancer and 20 participants with benign breast tumors. The detector will be directly placed on each breast, while the participant is in supine position, without a coupling medium. Confocal images will be created based on the analyzed data, and the presence of breast tumors will be assessed. The primary endpoint will be the diagnostic accuracy, sensitivity, and specificity of the detector for breast cancer and benign tumors. The secondary endpoint will be the safety and detectability of each molecular subtype of breast cancer. For an exploratory endpoint, the influence of breast density and tumor size on tumor detection will be investigated.
RESULTS RESULTS
Recruitment began in November 2018 and was completed by March 2020. We anticipate the preliminary results to be available by summer 2021.
CONCLUSIONS CONCLUSIONS
This study will provide insights on the diagnostic accuracy of microwave breast imaging using a rotational bistatic impulse radar. The collected data will improve the diagnostic algorithm of microwave imaging and lead to enhanced device performance.
TRIAL REGISTRATION BACKGROUND
Japan Registry of Clinical Trials jRCTs062180005; https://jrct.niph.go.jp/en-latest-detail/jRCTs062180005.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) UNASSIGNED
DERR1-10.2196/17524.

Identifiants

pubmed: 33074156
pii: v9i10e17524
doi: 10.2196/17524
pmc: PMC7605985
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e17524

Informations de copyright

©Shinsuke Sasada, Norio Masumoto, Hang Song, Akiko Emi, Takayuki Kadoya, Koji Arihiro, Takamaro Kikkawa, Morihito Okada. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 19.10.2020.

Références

IEEE Trans Biomed Eng. 2018 Nov;65(11):2580-2590
pubmed: 29993488
IEEE Trans Med Imaging. 2016 Jun;35(6):1501-9
pubmed: 26780788
Rural Remote Health. 2014;14(2):2730
pubmed: 24953122
Radiology. 2004 May;231(2):571-80
pubmed: 15128998
IEEE Trans Biomed Eng. 2017 Jan;64(1):40-51
pubmed: 26955012
Phys Med Biol. 2007 May 21;52(10):2637-56
pubmed: 17473342
Acad Radiol. 2007 Feb;14(2):207-18
pubmed: 17236994
Phys Med Biol. 1987 Jun;32(6):675-95
pubmed: 3039542
IEEE Trans Biomed Eng. 1988 Apr;35(4):257-63
pubmed: 2834285
J Med Imaging (Bellingham). 2018 Apr;5(2):025502
pubmed: 29900185
Lancet. 2016 Jan 23;387(10016):341-348
pubmed: 26547101
Jpn J Clin Oncol. 2015 Sep;45(9):884-91
pubmed: 26142437
IEEE Trans Biomed Eng. 1998 Dec;45(12):1470-9
pubmed: 9835195
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Sci Rep. 2016 Feb 04;6:20459
pubmed: 26842761
J Med Imaging (Bellingham). 2016 Jul;3(3):033502
pubmed: 27446970
Ann Intern Med. 2016 Feb 16;164(4):256-67
pubmed: 26756737
Nature. 1949 Mar 26;163(4143):487
pubmed: 18115108
N Engl J Med. 2007 Jan 18;356(3):227-36
pubmed: 17229950
Radiology. 2007 May;243(2):350-9
pubmed: 17400760
Phys Med Biol. 2007 Oct 21;52(20):6093-115
pubmed: 17921574
IEEE Trans Biomed Eng. 2016 Mar;63(3):530-9
pubmed: 26259214
Jpn J Clin Oncol. 2016 May;46(5):482-92
pubmed: 27207993
IEEE Trans Biomed Eng. 2008 Jun;55(6):1697-704
pubmed: 18714833
IEEE Trans Biomed Eng. 2002 Aug;49(8):812-22
pubmed: 12148820
Med Phys. 2017 Dec;44(12):e446-e458
pubmed: 28976568

Auteurs

Shinsuke Sasada (S)

Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.

Norio Masumoto (N)

Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.

Hang Song (H)

Research Institute for Nanodevice and Bio Systems, Hiroshima University, Higashi-hiroshima, Japan.

Akiko Emi (A)

Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.

Takayuki Kadoya (T)

Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.

Koji Arihiro (K)

Department of Anatomical Pathology, Hiroshima University Hospital, Hiroshima, Japan.

Takamaro Kikkawa (T)

Research Institute for Nanodevice and Bio Systems, Hiroshima University, Higashi-hiroshima, Japan.

Morihito Okada (M)

Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.

Classifications MeSH